Novartis And Axovant Might Jointly Be Holding The Most Promising Neurodegeneration Drug In Development Seeking Alpha, 04 Jun 2019 Summary The global market for drugs to treat neurodegeneration is expected to grow with a compound annual rate of 8% through…
